Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Efficacy & Safety Outcomes With Pembro Rechallenge for Patients With Advanced/Metastatic Urothelial Cancer Who Responded to First-Course Treatment"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Vadim Koshkin
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Vadim Koshkin
188 views
November 15, 2023
Comments 0
Login to view comments.
Click here to Login
Genitourinary